Ionsys (fentanyl hydrochloride): EMEA recommends the suspension of its marketing authorisation
Press release about the suspension of Ionsys (fentanyl hydrochloride) marketing authorisation The European Medicines Agency (EMEA) has recommended the suspension of the marketing authorisation of Ionsys (fentanyl hydrochloride), from Janssen-Cilag International NV, because of a defect with the delivery system of the medicine that could lead to patients being overdosed. Ionsys is a system for the transdermal […]